Heterophilic antibodies in sera from individuals without loxoscelism cross-react with phospholipase D from the venom of and spiders.

J Venom Anim Toxins Incl Trop Dis

1Laboratory of Molecular Parasitology, Department of Medical Technology, Faculty of Health Sciences, University of Antofagasta, 1270300 Antofagasta, Chile.

Published: July 2018

Background: Loxoscelism is a severe human envenomation caused by spider venom. To the best of our knowledge, no study has evaluated the presence of antibodies against venom in loxoscelism patients without treatment with antivenom immunotherapy. We perform a comparative analysis for the presence of antibodies capable of recognizing venom in a group of patients diagnosed with loxoscelism and in a group of people without loxoscelism.

Methods: The detection of venom, venom and recombinant phospholipases D from (PLDs) in sera from people with loxoscelism (Group 1) and from healthy people with no history of loxoscelism (Group 2) was evaluated using immuno-dot blot, indirect ELISA, and Western blot.

Results: We found naturally heterophilic antibodies (IgG-type) in people without contact with spiders or any clinical history of loxoscelism. Either serum pools or single sera from Group 1 and Group 2 analyzed by dot blot tested positive for venom. Indirect ELISA for venom recognition showed titles of 1:320 for Group 1 sera and 1:160 for Group 2 sera. Total IgG quantification showed no difference in sera from both groups. Pooled sera and purified IgG from sera of both groups revealed venom proteins between 25 and 32 kDa and the recombinant phospholipase D isoform 1 (rLlPLD1), specifically. Moreover, heterophile antibodies cross-react with PLDs from other species and the venom of spider.

Conclusions: People without contact with the spider venom produced heterophilic antibodies capable of generating a cross-reaction against the venom of and spiders. Their presence and possible interference should be considered in the development of immunoassays for venom detection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062995PMC
http://dx.doi.org/10.1186/s40409-018-0155-xDOI Listing

Publication Analysis

Top Keywords

venom
13
heterophilic antibodies
12
loxoscelism group
12
sera
8
venom spiders
8
spider venom
8
presence antibodies
8
antibodies capable
8
group
8
history loxoscelism
8

Similar Publications

Background: Current guidelines recommend application of the 99th percentile to determine the cut-off value on at least 120 healthy donors regardless of sex for lupus anticoagulant (LA) ratio of each step. However, a statistically significant difference between the sexes has been found for LA ratio recently.

Objectives: To clarify whether this sex difference in dilute Russell's viper venom time (DRVVT) exists in various detection systems and the necessity of setting sex-specific cut-off values.

View Article and Find Full Text PDF

Tandem duplication of genes can play a critical role in the evolution of functional novelty, but our understanding is limited concerning gene duplication's role in coevolution between species. Much is known about the evolution and function of tandemly duplicated snake venom genes, however the potential of gene duplication to fuel venom resistance within prey species is poorly understood. In this study, we characterize patterns of gene duplication of the SERPINA subfamily of genes across in vertebrates and experimentally characterize functional variation in the SERPINA3-like paralogs of a wild rodent.

View Article and Find Full Text PDF

New Frontiers in Fighting Mycobacterial Infections: Venom-Derived Peptides.

Probiotics Antimicrob Proteins

January 2025

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.

Notwithstanding the indefatigable endeavors to develop effective anti-mycobacterial therapies, mycobacterial infections still present a tough problem for medicine today. The problem is further complicated by the disquieting surge of drug-resistant mycobacterial pathogens, which considerably narrows the existing therapeutic options. Thus, there is a genuine need to discover novel anti-mycobacterial drugs.

View Article and Find Full Text PDF

Bee venom (BV) represents a promising natural alternative to conventional antibiotics, particularly significant given its broad-spectrum antimicrobial activity and potential to address the growing challenge of antimicrobial resistance. The prevalence of antimicrobial-resistant microorganisms (AMR) is a global burden that affects human health and the economies of different countries. As a result, several scientific communities around the world are searching for safe alternatives to antibiotics.

View Article and Find Full Text PDF

Scientists are turning to AI to make antivenoms cheaper, faster, and more effective.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!